Lv11
22 积分 2023-02-08 加入
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
6小时前
已完结
High-Risk Features Associated with Recurrence in Stage I Lung Adenocarcinoma
2个月前
已完结
EP12.01-01 The Safety and Efficacy of Aumolertinib in Advanced NSCLC Patients with EGFRm Who were Intolerant to Osimertinib: A Retrospective Clinical Study
2个月前
已完结
EP08.02-137 Prospective Study of Aumolertinib in NSCLC Patients with EGFR Sensitive Mutations Who Are Intolerant to Osimertinib Treatment
2个月前
已完结
Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer
2个月前
已完结
Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA)
2个月前
已完结
Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
5个月前
已完结
Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results
5个月前
已完结
Efficacy and safety of adjuvant EGFR TKI alone and in combination with chemotherapy for resected EGFR mutation-positive non-small cell lung cancer: A Bayesian network meta-analysis
7个月前
已完结
Prevalence of EGFR Mutations in Patients With Resected Stage I-III NSCLC: Results From the EARLY-EGFR Study
7个月前
已完结
皖公网安备34019202002308
